1.
Annual epidemiological report 2016. European Centre for Disease Prevention and Control.
2016.
2.
Prevention CfDCa. Active Bacterial Core surveillance (ABCs) . 2013 -present.
3.
Lujan M, Burgos J, Gallego M, Falco V, Bermudo G, Planes A, et al. Effects of immunocompromise
and comorbidities on pneumococcal serotypes causing invasive respiratory infection
in adults: implications for vaccine strategies. Clinical infectious diseases : an
official publication of the Infectious Diseases Society of America. 2013;57(12):1722-30.
4.
Kumar D, Humar A, Plevneshi A, Green K, Prasad GV, Siegal D, et al. Invasive pneumococcal
disease in solid organ transplant recipients--10-year prospective population surveillance.
American journal of transplantation : official journal of the American Society of
Transplantation and the American Society of Transplant Surgeons. 2007;7(5):1209-14.
5.
Cordero E, Pachon J, Rivero A, Giron JA, Gomez-Mateos J, Merino MD, et al. Community-acquired
bacterial pneumonia in human immunodeficiency virus-infected patients: validation
of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.
American journal of respiratory and critical care medicine. 2000;162(6):2063-8.
6.
Linnemann CC, Jr., First MR. Risk of pneumococcal infections in renal transplant patients.
Jama. 1979;241(24):2619-21.
7.
Amber IJ, Gilbert EM, Schiffman G, Jacobson JA. Increased risk of pneumococcal infections
in cardiac transplant recipients. Transplantation. 1990;49(1):122-5.
8.
de Bruyn G, Whelan TP, Mulligan MS, Raghu G, Limaye AP. Invasive pneumococcal infections
in adult lung transplant recipients. American journal of transplantation : official
journal of the American Society of Transplantation and the American Society of Transplant
Surgeons. 2004;4(8):1366-71.
9.
Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, et al. An international
prospective study of pneumococcal bacteremia: correlation with in vitro resistance,
antibiotics administered, and clinical outcome. Clinical infectious diseases : an
official publication of the Infectious Diseases Society of America. 2003;37(2):230-7.
10.
Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive
disease potential, clinical presentations, and antibiotic resistance. Journal of Korean
medical science. 2013;28(1):4-15.
11.
III SdIMCNdEIdSC. INFORME ANUAL DEL SISTEMA DE INFORMACIÓN MICROBIOLÓGICA 2012. 2014.
12.
Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause
the most invasive disease: implications for conjugate vaccine formulation and use,
part I. Clinical infectious diseases : an official publication of the Infectious Diseases
Society of America. 2000;30(1):100-21.
13.
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly
report Recommendations and reports. 1997;46(RR-8):1-24.
14.
(CDC). CfDCaP. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal
polysaccharide vaccine for adults with immunocompromising conditions: recommendations
of the Advisory Committee on Immunization Practices (ACIP). Mmwr Morb Mortal Wkly
Rep. 2012;61(40):816–9.
15.
Danziger-Isakov L, Kumar D, Practice ASTIDCo. Vaccination in solid organ transplantation.
American journal of transplantation : official journal of the American Society of
Transplantation and the American Society of Transplant Surgeons. 2013;13 Suppl 4:311-7.
16.
Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, et al. Influenza vaccination
coverage among adult solid organ transplant recipients at three health maintenance
organizations, 1995-2005. Vaccine. 2009;27(17):2335-41.
17.
Diana A, Posfay-Barbe KM, Belli DC, Siegrist CA. Vaccine-induced immunity in children
after orthotopic liver transplantation: a 12-yr review of the Swiss national reference
center. Pediatric transplantation. 2007;11(1):31-7.
18.
Eckerle I, Rosenberger KD, Zwahlen M, Junghanss T. Serologic vaccination response
after solid organ transplantation: a systematic review. PloS one. 2013;8(2):e56974.
19.
van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia.
Lancet. 2009;374(9700):1543-56.
20.
Obando I, Sanchez-Tatay D, Molinos-Quintana A, Delgado-Pecellin I, Porras A, Morillo-Gutierrez
B, et al. [Epidemiology of nasopharyngeal carriage of Streptococcus pneumoniae in
children < 6 years old in Seville]. Enfermedades infecciosas y microbiologia clinica.
2011;29(8):581-6.
21.
Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, et al. Nasopharyngeal
carriage of Streptococcus pneumoniae by adults and children in community and family
settings. Clinical infectious diseases : an official publication of the Infectious
Diseases Society of America. 2004;38(5):632-9.
22.
Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key
to pneumococcal disease. The Lancet Infectious diseases. 2004;4(3):144-54.
23.
Glennie SJ, Banda D, Gould K, Hinds J, Kamngona A, Everett DD, et al. Defective pneumococcal-specific
Th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization.
Clinical infectious diseases : an official publication of the Infectious Diseases
Society of America. 2013;56(2):291-9.
24.
Nicoletti C, Brandileone MC, Guerra ML, Levin AS. Prevalence, serotypes, and risk
factors for pneumococcal carriage among HIV-infected adults. Diagnostic microbiology
and infectious disease. 2007;57(3):259-65.
25.
Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Sampling methods for the study of
pneumococcal carriage: a systematic review. Vaccine. 2012;30(48):6738-44.
26.
O'Brien KL, Nohynek H, World Health Organization Pneumococcal Vaccine Trials Carriage
Working G. Report from a WHO Working Group: standard method for detecting upper respiratory
carriage of Streptococcus pneumoniae. The Pediatric infectious disease journal. 2003;22(2):e1-11.
27.
Ing J, Mason EO, Kaplan SL, Lamberth LB, Revell PA, Luna RA, et al. Characterization
of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994
to 2010. Journal of clinical microbiology. 2012;50(4):1326-30.
28.
Ma X, Zhao R, Ma Z, Yao K, Yu S, Zheng Y, et al. Serotype distribution and antimicrobial
resistance of Streptococcus pneumoniae isolates causing invasive diseases from Shenzhen
Children's Hospital. PloS one. 2013;8(6):e67507.
29.
CLSI CaLSI-. Performance Standards for Antimicrobial Susceptibility Testing. Clinical
and Laboratory Standards Institute 2018.
30.
Iraurgui P, Torres MJ, Gandia A, Vazquez I, Cabrera EG, Obando I, et al. Modified
sequential multiplex PCR for determining capsular serotypes of invasive pneumococci
recovered from Seville. Clinical microbiology and infection : the official publication
of the European Society of Clinical Microbiology and Infectious Diseases. 2010;16(9):1504-7.
31.
Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, et al. PCR-based
discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F. Journal
of microbiological methods. 2018;144:99-106.
32.
Shakrin NN, Balasubramaniam SD, Yusof HA, Mastuki MF, Masri SN, Taib NM, et al. Evaluation
of PCR-based approach for serotype determination of Streptococcus pneumoniae. Tropical
biomedicine. 2013;30(2):338-44.
33.
Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA. The descriptive epidemiology of Streptococcus
pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults
in Kilifi district, Kenya. The Pediatric infectious disease journal. 2008;27(1):59-64.
34.
Flamaing J, Peetermans WE, Vandeven J, Verhaegen J. Pneumococcal colonization in older
persons in a nonoutbreak setting. Journal of the American Geriatrics Society. 2010;58(2):396-8.
35.
Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM. Nasopharyngeal carriage
of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly
subjects. Scandinavian journal of infectious diseases. 2012;44(6):433-8.
36.
Almeida ST, Nunes S, Santos Paulo AC, Valadares I, Martins S, Breia F, et al. Low
prevalence of pneumococcal carriage and high serotype and genotype diversity among
adults over 60 years of age living in Portugal. PloS one. 2014;9(3):e90974.
37.
Allemann A, Frey PM, Brugger SD, Hilty M. Pneumococcal carriage and serotype variation
before and after introduction of pneumococcal conjugate vaccines in patients with
acute otitis media in Switzerland. Vaccine. 2017;35(15):1946-53.
38.
Ousmane S, Diallo BA, Ouedraogo R, Sanda AA, Soussou AM, Collard JM. Serotype Distribution
and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy
Toddlers before PCV13 Introduction in Niamey, Niger. PloS one. 2017;12(1):e0169547.
39.
Numminen E, Chewapreecha C, Turner C, Goldblatt D, Nosten F, Bentley SD, et al. Climate
induces seasonality in pneumococcal transmission. Scientific reports. 2015;5:11344.
40.
Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavalda J, Moreno A, et al. Two
Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant
Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. Clinical
infectious diseases : an official publication of the Infectious Diseases Society of
America. 2017;64(7):829-38.
41.
Miyazaki H, Shibuya R, Midorikawa N, Chang B, Ohnishi M, Matsumoto T. Serotype distribution
and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan
after introduction of the routine immunization program. Journal of infection and chemotherapy
: official journal of the Japan Society of Chemotherapy. 2017;23(4):234-40.
42.
Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, et al. Emergence of Multidrug-Resistant
Pneumococcal Serotype 35B among Children in the United States. Journal of clinical
microbiology. 2017;55(3):724-34.
43.
Mendes RE, Hollingsworth RC, Costello A, Jones RN, Isturiz RE, Hewlett D, Jr., et
al. Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult
patients in the United States in 2009 to 2012. Antimicrobial agents and chemotherapy.
2015;59(9):5595-601.
44.
Ubukata K, Chiba N, Hanada S, Morozumi M, Wajima T, Shouji M, et al. Serotype Changes
and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations
in Children, Japan, 2010-2013. Emerging infectious diseases. 2015;21(11):1956-65.
45.
(ECDC) ECfDPaC. Surveillance of invasive pneumococcal disease in Europe, 2010. . 2012.
46.
Beall B, McEllistrem MC, Gertz RE, Jr., Boxrud DJ, Besser JM, Harrison LH, et al.
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus
pneumoniae within the United States. The Journal of infectious diseases. 2002;186(1):118-22.
47.
van Veen KE, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in solid
organ transplant recipients: a population-based prospective study. Transplant infectious
disease : an official journal of the Transplantation Society. 2016;18(5):674-80.